Monique Lafon scientific advisor of Neurophoenix

Monique Lafon, Scientific Advisor

Monique is director of the laboratory of Viral Neuro-Immunology of Institut Pasteur (Paris) since 2001. Former student of the Ecole Normale Supérieure, cum laude in biological sciences, Monique Lafon holds a PhD in biochemistry of the University of Paris Descartes.

In the laboratory of Viral Neuro-Immunology at the Institut Pasteur, Monique Lafon’s research focuses on the rabies virus, a neurotropic virus that causes lethal encephalitis.  Monique Lafon has published more than a hundred articles in various international scientific journals.

Tom Shepherd, Chief Executive Officer

Tom has more than 30 years of experience leading and developing biotech companies in France and internationally (United States, United Kingdom, Switzerland, Australia and South Korea) with in-depth skills in the formulation and execution of business strategy, the development of therapeutic products and technologies, accessing capital, business development, license negotiation, mergers and acquisitions.

He holds a PhD in Biochemistry from the University of Strathclyde in Scotland and a Continuing Executive Program from the London Business School.

Tom Shepherd CEO of Neurophoenix
Pascal Voisin Chairman of Neurophoenix

Pascal Voisin, Chairman

Pascal is an entrepreneur and a business angel, member of the Angels Santé network since September 2016. With 30 years of experience in the management of companies in the financial sector both in France and abroad, he brings to the company his general knowledge of management, business development and his knowledge of the financial world and investors.

He is a graduate of HEC and holds a DEA in economics from the University of Paris Ouest.